XML 96 R78.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation, Stock Options (Details) - USD ($)
$ / shares in Units, $ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Number of Shares [Roll Forward]      
Exercised (in shares) (1,200,000) (700,000) (400,000)
Stock Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 2,758,300    
Granted (in shares) 0    
Exercised (in shares) (680,500)    
Forfeited/cancelled/expired (in shares) (452,300)    
Outstanding at end of year (in shares) 1,625,500 2,758,300  
Exercisable at end of year (in shares) 1,122,500    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 39.9    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 31.65    
Forfeited/cancelled/expired (in dollars per share) 50.95    
Outstanding at end of year (in dollars per share) 40.04 $ 39.9  
Exercisable at end of year (in dollars per share) $ 39.2    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 3 years 6 months 10 days    
Outstanding options, aggregate intrinsic value $ 10,349    
Exercisable options, weighted-average remaining contractual term 2 years 11 months 15 days    
Exercisable options, aggregate intrinsic value $ 8,027    
Service-Based Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 538,200    
Granted (in shares) 0    
Exercised (in shares) (340,000)    
Forfeited/cancelled/expired (in shares) (34,300)    
Outstanding at end of year (in shares) 163,900 538,200  
Exercisable at end of year (in shares) 163,900    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 35.89    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 33.15    
Forfeited/cancelled/expired (in dollars per share) 54.45    
Outstanding at end of year (in dollars per share) 37.69 $ 35.89  
Exercisable at end of year (in dollars per share) $ 37.69    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 4 months 6 days    
Outstanding options, aggregate intrinsic value $ 834    
Exercisable options, weighted-average remaining contractual term 4 months 6 days    
Exercisable options, aggregate intrinsic value $ 834    
Performance-Based Options [Member]      
Number of Shares [Roll Forward]      
Outstanding at beginning of year (in shares) 2,220,100    
Granted (in shares) 0    
Exercised (in shares) (340,500)    
Forfeited/cancelled/expired (in shares) (418,000)    
Outstanding at end of year (in shares) 1,461,600 2,220,100  
Exercisable at end of year (in shares) 958,600    
Weighted-Average Exercise Price [Roll Forward]      
Outstanding at beginning of year (in dollars per share) $ 40.87    
Granted (in dollars per share) 0    
Exercised (in dollars per share) 31.14    
Forfeited/cancelled/expired (in dollars per share) 50.66    
Outstanding at end of year (in dollars per share) 40.3 $ 40.87  
Exercisable at end of year (in dollars per share) $ 39.46    
Remaining Contractual Term and Aggregate Intrinsic Value [Abstract]      
Outstanding options, weighted-average remaining contractual term 3 years 10 months 20 days    
Outstanding options, aggregate intrinsic value $ 9,515    
Exercisable options, weighted-average remaining contractual term 3 years 4 months 28 days    
Exercisable options, aggregate intrinsic value $ 7,193